RAF1 and melanoma: In melanoma, most cases with altered NF1 comprise loss-of-function mutation [36], in which neurofibromin loses its capacity to inactivate Ras and promotes sustained stimulation of Raf and its downstream targets, leading to overstimulation of the MAPK pathway and consequent cell growth, proliferation, and survival [63].